Eli Lilly’s GLP-one franchise keeps it central to pharma growth as demand, manufacturing scale, pipeline progress, and ...

The National Family Health Survey-6 is the most comprehensive picture of India’s health in four years. And if you read only ...

Community health workers fill the gaps in places without enough doctors and nurses. Trump’s budget cuts are costing them ...

Discusses Obesity and Diabetes Portfolio Progress and Pill Launch Milestones at R&D Event June 7, 2026 7:30 PM ...

Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, announced today that Noreen R. Henig, MD, Chief Medical Officer, ...

The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks." ...

Lead asset CAD-1005 being researched for prevention of life-threatening blood clots in patients with Heparin-induced Thrombocytopenia (HIT), ...

The market is underestimating these companies' long-term prospects.

Significant underdiagnosis of chronic kidney disease (CKD), now the ninth leading cause of death globally, is endangering ...

HealthInvest showcased ASX-listed healthcare companies where scientific innovation, commercial opportunity and patient outcomes align.

People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular ...

The Federal Government warns that unsafe food causes over 53,000 deaths and 50 million illnesses annually in Nigeria. Learn ...